Correspondence on: ‘Dupilumab as a novel steroid-sparing treatment for IgG 4 -related disease’ by Simpson et al

Mikael Ebbo (1, 2) , Benjamin de Sainte-Marie (2) , Romain Muller (2) , Christelle Piperoglou (2) , Aurélie Grados (3) , Frédéric Vély (2, 1) , Nicolas Schleinitz (2, 1)

1 CIML - Centre d'Immunologie de Marseille - Luminy
2 TIMONE - Hôpital de la Timone [CHU - APHM]
3 Centre hospitalier de Niort

Domains: Life Sciences [q-bio]

Mikael Ebbo, Benjamin de Sainte-Marie, Romain Muller, Christelle Piperoglou, Aurélie Grados, et al.. Correspondence on: ‘Dupilumab as a novel steroid-sparing treatment for IgG 4 -related disease’ by Simpson et al. Annals of the Rheumatic Diseases, 2022, 81 (2), pp.e26-e26. ⟨10.1136/annrheumdis-2020-217010⟩. ⟨hal-03933642⟩